Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistanceKari Fischer, Dingcheng Gao, Seongho Ryu et al.|Nature|2015Cited by 1.8k
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trialEnriqueta Felip, Heather A. Wakelee, Nasser K. Altorki et al.|The Lancet|2021Cited by 1.5k
Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal CancerReem Z. Sharaiha, Julian A. Abrams, Karim J. Halazun et al.|Annals of Surgical Oncology|2011Cited by 331
Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial TransitionDingcheng Gao, Vivek Mittal, Natasha Joshi et al.|Cancer Research|2012Cited by 305
Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trialEnriqueta Felip, H. Wakelee, Nasser K. Altorki et al.|Annals of Oncology|2023Cited by 251